VICP 주가 차트
VICP 수입
Vicapsys Life Sciences Inc
$1.45
0%
$0
종가: Aug 12, 16:00:00 GMT-4
$1.45
0%
$0
애프터마켓: Aug 12, 20:00:00 GMT-4
뒤로
Vicapsys Life Sciences Inc (VICP) 수입
아직 데이터 없음Earnings FAQ
VICP의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Vicapsys Life Sciences Inc VICP의 지난 분기 매출 실적은 어땠나요?
Vicapsys Life Sciences Inc의 매출 추정치는 얼마인가요?
Vicapsys Life Sciences Inc의 수익 품질 점수는 얼마인가요?
Vicapsys Life Sciences Inc는 언제 수익을 보고하나요?
Vicapsys Life Sciences Inc의 예상 수익은 얼마인가요?
Vicapsys Life Sciences Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$1.45
시가
$0.51
일일 범위
$0.51 - $1.45
52주 범위
$0.15 - $1.77
거래량
100
평균 거래량
20
배당수익률
--
EPS(TTM)
--
시가총액
$46.9M
VICP란 무엇인가요?
Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. The company is headquartered in Cumming, Georgia and currently employs 2 full-time employees. The company went IPO on 2001-07-11. VICAPSYN is the Company’s product line that is applied to transplantation therapies and related stem-cell applications in the transplantation field. The lead product candidate embodiment in transplantation therapy to treat Type 1 Diabetes (T1D) is an encapsulated human islet cell cluster that is intended to restore normal glucose control when implanted into the peritoneal cavity of a patient. The company also develops another product candidate line based on CXCL12 with the trade name of VYBRIN. The clinical applications of VYBRIN are being explored in several areas, including prevention of post-surgical adhesions in abdominal surgery, and others.
